Trade Viatris Inc. - VTRS CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.09 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 7.99 |
| Open | 7.94 |
| 1-Year Change | -31.02% |
| Day's Range | 7.91 - 8.08 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 25, 2025 | 8.08 | 0.13 | 1.64% | 7.95 | 8.09 | 7.89 |
| Apr 24, 2025 | 7.99 | 0.19 | 2.44% | 7.80 | 8.08 | 7.78 |
| Apr 23, 2025 | 7.77 | -0.04 | -0.51% | 7.81 | 8.05 | 7.76 |
| Apr 22, 2025 | 7.65 | 0.05 | 0.66% | 7.60 | 7.71 | 7.56 |
| Apr 21, 2025 | 7.53 | 0.05 | 0.67% | 7.48 | 7.58 | 7.42 |
| Apr 17, 2025 | 7.51 | 0.13 | 1.76% | 7.38 | 7.57 | 7.35 |
| Apr 16, 2025 | 7.34 | -0.13 | -1.74% | 7.47 | 7.58 | 7.29 |
| Apr 15, 2025 | 7.44 | -0.10 | -1.33% | 7.54 | 7.62 | 7.35 |
| Apr 14, 2025 | 7.57 | -0.05 | -0.66% | 7.62 | 7.65 | 7.38 |
| Apr 11, 2025 | 7.48 | 0.21 | 2.89% | 7.27 | 7.51 | 7.17 |
| Apr 10, 2025 | 7.21 | -0.34 | -4.50% | 7.55 | 7.55 | 6.81 |
| Apr 9, 2025 | 7.75 | 0.63 | 8.85% | 7.12 | 7.82 | 6.99 |
| Apr 8, 2025 | 7.33 | -0.52 | -6.62% | 7.85 | 7.94 | 7.17 |
| Apr 7, 2025 | 7.57 | 0.08 | 1.07% | 7.49 | 7.74 | 7.10 |
| Apr 4, 2025 | 7.58 | -0.45 | -5.60% | 8.03 | 8.08 | 7.54 |
| Apr 3, 2025 | 8.11 | -0.38 | -4.48% | 8.49 | 8.52 | 8.10 |
| Apr 2, 2025 | 8.62 | 0.12 | 1.41% | 8.50 | 8.67 | 8.49 |
| Apr 1, 2025 | 8.54 | -0.12 | -1.39% | 8.66 | 8.66 | 8.52 |
| Mar 31, 2025 | 8.67 | 0.10 | 1.17% | 8.57 | 8.75 | 8.51 |
| Mar 28, 2025 | 8.63 | -0.20 | -2.27% | 8.83 | 8.84 | 8.58 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Viatris Inc. Company profile
Viatris (VTRS) is a global healthcare company. It was formed in 2020 through the merger of Pfizer’s (PFE) off-patent branded and generic medicines division Upjohn and pharmaceutical firm Mylan.
The merger of Mylan and Upjohn was announced in July 2019 and received final regulatory clearance in October 2020. Pfizer shareholders own 57% of Viatris and Mylan shareholders own 43%, according to the merger announcement. Viatris started trading on the Nasdaq Stock Exchange under the ticker VTRS in November 2020.
Viatris is headquartered in Canonsburg, Pittsburgh, US. The company is operational in over 165 countries and has global centres in Shanghai, China and Hyderabad, India.
Viatris operates about 40 manufacturing sites which produce oral solid doses, injectables, complex dosage forms and active pharmaceutical ingredients. The firm also produces numerous complex generics, biosimilars and global key brands.
Viatris offers treatment options across more than 10 major therapeutic areas covering a wide variety of non-communicable and infectious diseases. According to the company’s website, 50% of its total active pharmaceutical ingredient (API) capacity is devoted to antiretroviral (ARV), which is used against HIV infection.
Some of the well-known and key brands under Viatris are anxiety treatment drug Xanax, antidepressant Zoloft, anti-inflammatory drug Celebrex and erectile dysfunction therapy Viagra, among others. Viatris also offers global biosimilars franchises focused on the areas of oncology, immunology, endocrinology, ophthalmology and dermatology.
| Industry: | Pharmaceuticals (NEC) |
1000 Mylan Boulevard
CANONSBURG
PENNSYLVANIA 15317
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com